Project Grant T32AG082658
Award Date
9/15/24
Completion Date
9/14/29
Dollars Obligated
$341K
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Tempe, AZ 85287, USA
Similar Awards
This $585,650 Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) will fund the "Alzheimer's Disease Big Data to Biology Training Program (ADBDB-TP)" at Emory University over a 5-year period from September 2024 to August 2029. The program aims to train a diverse cohort of 4 pre- and post-doctoral candidates annually to develop expertise in leveraging "big data" approaches to advance the understanding and treatment of Alzheimer's...
This $1,177,500 federal Project Grant award from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866) supports the Arizona State University (ASU) Roybal Center for Older Adults Living Alone with Cognitive Decline. The center will develop and conduct clinical trials of technology-enabled behavioral and lifestyle interventions to delay Alzheimer's disease and related dementias (ADRD) and improve quality of life in older adults living alone with cognitive decline,...
This federal Project Grant award of $307,000.00 from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to conduct a single, highly powered study to identify memory processes that are most sensitive to the asymptomatic, preclinical stage of Alzheimer's disease (AD) pathology. The study combines a continuous report item-location associative memory task with advanced behavioral and neural modeling to estimate subtle changes in memory precision that may differentiate healthy...
The National Institute on Aging (NIA) awarded a Project Grant (CFDA 93.866 - Aging Research) in the amount of $661,016 to the University of Southern California (USC) to develop a "Federated Deep Learning to Accelerate Alzheimer's Disease Research" project. The key products and services to be delivered include: Establishing an international "Federate AD" alliance to leverage innovative AI techniques and distributed computation to study Alzheimer's disease (AD) across large,...
This federal Project Grant award, valued at $972,000.00 and awarded by the National Institute on Aging (CFDA 93.866 - Aging Research), aims to characterize the genetic architecture underlying the onset of amyloid positivity in Alzheimer's disease (AD). The principal investigator will leverage advanced imaging and genetic analysis techniques, including artificial intelligence, to estimate the age of amyloid-beta onset from over 16,000 positron emission tomography scans. This research seeks to...
This federal Project Grant award, provided by the National Institute on Aging under the Aging Research program (CFDA 93.866), supports research into the role of senescent cells in brain aging and Alzheimer's disease and related dementias (ADRD). The $654,238 award, with a start date of September 15, 2024 and an ultimate completion date of June 30, 2026, aims to generate high-resolution spatial omics data from ADRD brains and corresponding mouse models to identify molecular changes in the...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $622,401 to the University of Southern California (USC) to conduct advanced research on Alzheimer's disease and related dementias (ADRD). The project aims to develop novel deep learning and event-based modeling techniques to elucidate the causal sequence of brain biomarker changes that lead to ADRD, as well as identify modifiable lifestyle factors that may influence these brain alterations....
This federal Project Grant award of $1,055,595 from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to better understand how advancing age contributes to the occurrence and progression of Alzheimer's disease (AD). The key objectives are to: 1) determine how increasing endosome formation, the vehicles for endosome trafficking, can decrease tau protein accumulation in neurons, a hallmark of AD pathology; and 2) define how increasing endosome formation influences cognition and...
This $107,948 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to enhance understanding of the biological signatures that distinguish subgroups of patients with Alzheimer's disease (AD). The key goals are to: Determine if AD subtypes can be identified solely using magnetic resonance imaging (MRI)-derived features through the application of machine learning algorithms. Integrate epigenetic profiles, including small non-coding RNA expression and DNA...
This Project Grant award of $614,424 from the National Institute on Aging (CFDA 93.866 Aging Research program) supports research to illuminate early microglial dysfunction in Alzheimer's disease (AD). The study aims to integrate novel explainable AI techniques with deep learning methods to better define AD-specific microglial states and pathways from single-cell brain data. As proof-of-concept, the researchers will model the combined effects of AD stimuli and neuronal injury on...